There has been talk for some time of the potential for GPL-1 drugs like Ozempic and Wegovy to be useful in treating a multitude of other chronic conditions. Included are reports of unexpected pregnancies among women on GLP-1 treatment. As a result researchers have pondered as to the possible effects of GLP-1 drugs on fertility. Biopharma Dive detail an upcoming study designed to establish whether GLP-1 drugs specifically can help women with hormonal disorders and fertility. https://lnkd.in/eR7_FN4E
Discover International
Staffing and Recruiting
London, England 122,976 followers
Talent Solutions for Life Sciences
About us
Discover International - Visionary Life Science Talent Solutions Our expert teams find exceptional people faster Our innovative Talent and Consulting solutions mean we deliver faster at every stage and every challenge of the hiring process; our product offering brings together an extensive global and local network, specialist skills, strategic guidance, and dedicated experts working together as a team. We nurture long-term partnerships with our candidates, our clients and our stakeholders, who continually recommend us to their colleagues and peers. When our contacts move to a new company, they consistently approach us to support them in finding talent in their new organisation. This organic client acquisition is testament to all that we stand for at Discover, and we are proud that more than 90% of our clients are repeat customers. We help game-changing organizations grow, making a meaningful difference at every stage of the Life Science process, through finding brilliant people faster in: Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Regulatory Affairs, CMC, Quality & Compliance, Medical Writing & Communications, HEOR, Market Access, Commercial, Pharmacovigilance & Drug Safety, Technical Operations, Manufacturing, Preclinical.
- Website
-
http://www.discoverinternational.com
External link for Discover International
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Life Sciences, Pharmaceutical, Medical Devices, Clinical, Discovery, Medical, Clinical Research, Clinical Development, Medical Affairs, Drug Safety, Pharmacovigilance, Recruitment, Headhunting, Regulatory Affairs, Biotech, Biotechnology, Staffing, Contract Recruitment, CDMO, Quality & Technical Operations, Medical Writing, Medical Device Engineering, Engineering, Commercial, and Radiopharma
Locations
Employees at Discover International
Updates
-
🧠💜 June is Alzheimer’s & Brain Awareness Month! 💜🧠 At Discover International, we are committed to raising awareness about Alzheimer's disease and other dementias that affect millions of people worldwide, as well as brain cancer, which poses a serious threat to brain health. This month, we join the global movement to support those impacted and to advocate for more research and resources to combat these devastating conditions. Did you know? 🔹 Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases. 🔹 More than 6 million Americans are living with Alzheimer's, and by 2050, this number is projected to rise to nearly 13 million. 🔹 Alzheimer's is not a normal part of aging; it’s a progressive brain disease that leads to memory loss, cognitive decline, and eventually, loss of ability to carry out simple tasks. 🔹 Brain cancer is a malignant growth in the brain that can disrupt normal brain function and lead to severe neurological issues. 🔹 Glioblastoma is the most aggressive form of brain cancer, with approximately 14,000 new cases diagnosed each year in the United States. Join us in spreading awareness and making a difference. Together, we can support those affected by Alzheimer’s and brain cancer, and work towards a future without these diseases. #EndAlz #BrainCancerAwareness #AlzheimersAwareness #BrainHealth #AlzheimersAndBrainAwarenessMonth #DiscoverInternationalCares
-
Today, we join the nation in commemorating Juneteenth, a day that marks the emancipation of enslaved African Americans and celebrates the rich heritage and contributions of African American communities across the United States. This significant day serves as a powerful reminder of the ongoing journey toward equality, justice, and unity. What is Juneteenth? On June 19, 1865, Union soldiers arrived in Galveston, Texas, with the news that the Civil War had ended and that all enslaved individuals were free—over two years after President Lincoln's Emancipation Proclamation. Juneteenth, also known as Freedom Day or Emancipation Day, has since become a time to reflect on the struggles, achievements, and cultural legacy of Black Americans. Why We Celebrate: At Discover International, we believe in the power of diversity, inclusion, and equity. Juneteenth is not only a celebration of freedom but also an opportunity to acknowledge the resilience, creativity, and contributions of all cultures throughout history and in our present communities. #Juneteenth #FreedomDay #EmancipationDay #DiversityAndInclusion #DiscoverInternationalCares
-
A summary from ASCO 2024. The latest advances in Oncology Clinical Trials from ASCO 2024 according to Labiotech: 1. Giant Pharma present promising Oncology clinical data 2. Big Pharma KRAS inhibitors are yet to meet their mark 3. A number of young Biotech's present encouraging early data 4. Vaccines for cancer treatment and prevention standout at ASCO 2024 5. Cancer detection tests strive for accuracy Read Labiotech.eu's American Society of Clinical Oncology (ASCO) 2024 conference summary here: https://lnkd.in/dGgHVxuY
ASCO 2024: The latest advances in oncology clinical trials
https://www.labiotech.eu
-
Moderna cancer vaccine poised to transform the Melanoma landscape. Not long after reporting significant losses for 2023 (-$4.7Billion) and Q1 2024 (-1.2Billion) due to the fall in demand for its Covid-19 Spikevax vaccine, Moderna were presenting some altogether different news at ASCO2024. At the American Society of Clinical Oncology (ASCO) conference Moderna and Merck released more positive Phase II three-year data on their experimental cancer vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. Among new data, nearly 75% of patients who took the combination were alive without any signs or symptoms of their cancer returning at the 2½-year mark. That compares with 55.6% of patients who got Keytruda alone. The overall survival rate of patients who took the vaccine in combination with Keytruda was 96% after 2½ years. That compares with 90.2% among those who took Keytruda alone. As the companies previously announced, patients with severe forms of the cancer, known as melanoma, who received the combination were 49% less likely to die or have their cancer return than those who took Keytruda alone after roughly three years. The combination also slashed the risk of melanoma spreading to other parts of the body, or death, by 62%. https://lnkd.in/erRJUASw
ASCO24: Moderna/MSD's cancer vaccine may transform melanoma landscape - Pharmaceutical Technology
pharmaceutical-technology.com
-
Discover International reposted this
A British toddler has had her hearing restored after becoming the first person in the world to take part in a pioneering gene therapy trial with Regeneron, in a development that doctors say marks a new era in treating deafness. An incredible breakthrough from Regeneron and the original Decibel Therapeutics team, whom Regeneron acquired in August 2023. Opal Sandy was born unable to hear anything due to auditory neuropathy, a condition that disrupts nerve impulses travelling from the inner ear to the brain and can be caused by a faulty gene. After receiving an infusion containing a working copy of the gene during groundbreaking surgery that took just 16 minutes, the 18-month-old can hear almost perfectly and enjoys playing with toy drums. Watch a heart warming video from Sky News with Opal and her parents. #regeneron #decibeltherapeutics #healthimpact #genetherapy https://lnkd.in/edyQq3ns
Deaf toddler's hearing restored in world first gene therapy trial
news.sky.com
-
Goldman Sachs now predicts the global obesity market will be worth $130 Billion by 2030. The boosted projection underscores the building momentum in the GLP-1 market as more drug developers race to tap its potential, while established companies Novo Nordisk and Eli Lilly and Company aim to expand their hold. The obesity market is now set to reach $130 billion in just 6 years. That’s up from a prior forecast of $100 billion. https://lnkd.in/eizJBse6
Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
finance.yahoo.com
-
The top 20 highest paying countries for Biotech according to Insider Monkey. To list the highest paying countries for biotechnology, Insider Monkey identified the countries with the highest demand for biotechnologists and looked at the average salaries for biotechnologists in that country. The 20 with the highest average salaries were selected and have been ranked. Insider Monkey acquired the data for average salaries of biotechnologists for each country from the Economic Research Institute (ERI). https://lnkd.in/enNxd3N7
20 Highest Paying Countries for Biotechnology
insidermonkey.com
-
A British toddler has had her hearing restored after becoming the first person in the world to take part in a pioneering gene therapy trial with Regeneron, in a development that doctors say marks a new era in treating deafness. An incredible breakthrough from Regeneron and the original Decibel Therapeutics team, whom Regeneron acquired in August 2023. Opal Sandy was born unable to hear anything due to auditory neuropathy, a condition that disrupts nerve impulses travelling from the inner ear to the brain and can be caused by a faulty gene. After receiving an infusion containing a working copy of the gene during groundbreaking surgery that took just 16 minutes, the 18-month-old can hear almost perfectly and enjoys playing with toy drums. Watch a heart warming video from Sky News with Opal and her parents. #regeneron #decibeltherapeutics #healthimpact #genetherapy https://lnkd.in/edyQq3ns
Deaf toddler's hearing restored in world first gene therapy trial
news.sky.com